Purchase Order FA864922P0661
Award Date
6/30/22
Potential Completion Date
12/27/24
Potential Value
$750K
Federal Agency
Air Force Research Laboratory
Awardee
RX Bandz, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78732, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
228
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Department of the Air Force Materiel Command Research Laboratory to RX Bandz, LLC, a self-certified small disadvantaged and woman-owned business, under the Small Business Innovation Research (SBIR) program. The $49,887 contract is for Phase I research and development of RX Bandz's "RX BANDZ: BUILT FOR HEALTH, BUILT FOR LIFE" product, which involves developing the next generation of patient-centric auto-injectors to deliver a...
The U.S. Air Force has awarded a $12,334,570 firm fixed price definitive contract to RX Bandz, Inc., a small disadvantaged woman-owned business, for the development of a tactical injector kit containing ketamine. This STTR Phase III contract is set aside for total small business participation and has an ultimate completion date of October 1, 2029. RX Bandz, Inc. is a medical equipment manufacturer that specializes in patient-centric auto injectors and has received prior Department of Defense...
RX Bandz, LLC was awarded a definitive contract valued at approximately $1.8 million by the Department of the Air Force Materiel Command Research Laboratory to conduct Medical Research and Development in support of the Small Business Innovation Research Phase II Technology Application and Commercialization Funding Initiative. The prime contractor, RX Bandz, LLC RX Bandz Division, will perform the work at its facility located in Austin, Texas over a two-year period concluding in September 2025....
The Department of the Air Force Materiel Command Research Laboratory awarded a $749,988 firm fixed price purchase order to RX Bandz, LLC for research and development of an automatic injector system to administer ketamine to critically injured airmen under a Small Business Technology Transfer Phase II contract. The contract period of performance is from July 20, 2022 through October 20, 2023 and will be performed in Austin, Texas. The award is set aside for total small business participation.
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $167,468.64 firm fixed price definitive contract to RX Bandz, LLC of Austin, Texas on May 12, 2021. The contract is set aside for total small business and involves research and development under the Small Business Innovation Research (SBIR) Program Phase I. RX Bandz will perform the work as a self-certified small disadvantaged, woman-owned business. The contract supports the Army's...
This federal contract award, valued at $2,132.74, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of epinephrine auto-injectors, a critical medical supply for military healthcare facilities. The contract is a firm fixed-price delivery order with no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business. This contract...
This federal contract award, valued at $1,045.50, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is a delivery order under the DLA's Medical Supply Chain program, with a firm fixed-price pricing structure and a period of performance through May 24, 2024. The contract provides for the delivery of epinephrine injection USP 1:1000 autoinjectors to support the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of epinephrine auto-injectors to the U.S. Department of Defense. The contract has a ceiling value of $1,700.00 and is a firm fixed-price delivery order. It was issued under an indefinite delivery vehicle (IDV) contract with the Defense Logistics Agency valued at up to $4,999,999 through 2025. This IDV enables the DLA to issue delivery orders for a broad range of pharmaceutical...
This federal contract award, with identification number SPE2DX16D9991|SPE2DX24FPLDF, is for the delivery of epinephrine auto-injectors to the U.S. government. The contract was awarded on April 16, 2024 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $3,400.00 and an ultimate completion date of April 17, 2024. The contract was awarded by the Defense Logistics Agency (DLA) under its...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois, is for the delivery of epinephrine auto-injectors to the U.S. Defense Logistics Agency (DLA). The contract has a ceiling value of $1,700.00 and a period of performance through March 12, 2024. The contract is a firm fixed-price delivery order issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract #4600082013 with the DLA, valued up to...